Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Predicting resistance to endocrine therapy in breast cancer: It's time for epigenetic biomarkers (Review).

Fontes-Sousa M, Amorim M, Salta S, Palma De Sousa S, Henrique R, Jerónimo C.

Oncol Rep. 2019 Mar;41(3):1431-1438. doi: 10.3892/or.2019.6967. Epub 2019 Jan 11. Review.


A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.

Salta S, P Nunes S, Fontes-Sousa M, Lopes P, Freitas M, Caldas M, Antunes L, Castro F, Antunes P, Palma de Sousa S, Henrique R, Jerónimo C.

J Clin Med. 2018 Nov 7;7(11). pii: E420. doi: 10.3390/jcm7110420.


Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women.

Nunes SP, Moreira-Barbosa C, Salta S, Palma de Sousa S, Pousa I, Oliveira J, Soares M, Rego L, Dias T, Rodrigues J, Antunes L, Henrique R, Jerónimo C.

Cancers (Basel). 2018 Sep 26;10(10). pii: E357. doi: 10.3390/cancers10100357.


FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome.

Schrijver W, Schuurman K, van Rossum A, Droog M, Jeronimo C, Salta S, Henrique R, Wesseling J, Moelans C, Linn SC, van den Heuvel M, van Diest P, Zwart W.

Mol Oncol. 2018 Nov;12(11):1884-1894. doi: 10.1002/1878-0261.12353. Epub 2018 Oct 12.


A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.

Ramalho-Carvalho J, Gonçalves CS, Graça I, Bidarra D, Pereira-Silva E, Salta S, Godinho MI, Gomez A, Esteller M, Costa BM, Henrique R, Jerónimo C.

Clin Epigenetics. 2018 Mar 27;10:40. doi: 10.1186/s13148-018-0475-2. eCollection 2018.


A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.

Freitas M, Ferreira F, Carvalho S, Silva F, Lopes P, Antunes L, Salta S, Diniz F, Santos LL, Videira JF, Henrique R, Jerónimo C.

J Transl Med. 2018 Feb 27;16(1):45. doi: 10.1186/s12967-018-1415-9.


Decoding the usefulness of non-coding RNAs as breast cancer markers.

Amorim M, Salta S, Henrique R, Jerónimo C.

J Transl Med. 2016 Sep 15;14:265. doi: 10.1186/s12967-016-1025-3. Review.

Supplemental Content

Loading ...
Support Center